VITAPULP: Experimental Research on Deep Carious Lesion Treatment of Molars

Sponsor
Carol Davila University of Medicine and Pharmacy (Other)
Overall Status
Completed
CT.gov ID
NCT03626740
Collaborator
(none)
40
1
2
32.9
1.2

Study Details

Study Description

Brief Summary

Maintaining dental pulp vitality is crucial for tooth preservation and functionality. Untreated dental caries may lead to pulp necrosis and infection, affecting children's growth and well-being. The first permanent teeth erupt around 6 years old. These are the first molars (FPM), which are frequently affected by caries, soon after their eruption.

In the present application, our main goal is to determine whether two treatment groups (MTA and TheraCal) are long-term effective in preserving pulp vitality among children' FPM affected by deep caries.

Condition or Disease Intervention/Treatment Phase
  • Other: TheraCal
  • Other: MTA
N/A

Detailed Description

Among the most frequently used materials for pulp capping are calcium hydroxide, mineral trioxide aggregate (MTA), and, more recent, TheraCal. All of them are biocompatible and induce the formation of coronal hard tissue barriers (tertiary reparative dentin). Calcium hydroxide, considered for a long time the gold standard of direct pulp capping materials, has excellent antibacterial and remineralisant properties; however, it lacks adhesion, especially at moist dentin, and reparative dentin is less homogenous.

MTA proved to stimulate protective dentin bridge formation without inflammatory changes and least necrosis. It is also moisture tolerant, but it is more expensive, has poor handling characteristics and slow setting time.

TheraCal bonds to deep moist dentin, has strong physical properties, no solubility, high radioopacity and higher calcium releasing abilities than MTA or calcium hydroxide.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Experimental Research on Deep Carious Lesion Treatment of Permanent Molars in Children, Aiming to Preserve Dental Pulp Vitality
Actual Study Start Date :
Jan 8, 2018
Actual Primary Completion Date :
Jun 30, 2020
Actual Study Completion Date :
Oct 4, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: TheraCal

Indirect pulp capping with TheraCal

Other: TheraCal
Caries removal without pulp exposure (stepwise excavation) followed by indirect pulp capping with TheraCal

Active Comparator: Mineral trioxide aggregate (MTA)

Indirect pulp capping with MTA

Other: MTA
Caries removal without pulp exposure (stepwise excavation) followed by indirect pulp capping with MTA

Outcome Measures

Primary Outcome Measures

  1. Clinical pulpal survival rate [20 months]

    Pulpal survival is defined by positive response without lingering sensation to the cold test, absence of clinical signs and symptoms, and no apical radiolucency on the periapical radiograph.

Secondary Outcome Measures

  1. Incidence of apical root maturation (apexogenesis) [20 months]

    We will investigate the treatment effect on apexogenesis in children who had incomplete root formation at the beginning of the study and preserve their pulp vitality at the end of the study. The outcome will be compared radiographically with apical maturation in molar pairs (healthy contralateral molar, where applicable).

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • untreated deep uncomplicated carious lesions in first permanent molars (FPM)

  • absence of clinical diagnosis of pulp exposure

  • fistula

  • swelling of periodontal tissues

  • abnormal tooth mobility

  • history of spontaneous pain or sensitivity to percussion

  • healthy appearance of adjacent gingiva

  • normal tooth color

  • positive vitality to thermal and electric tests.

Exclusion Criteria:
  • FPM with previous treatment

  • FPM with developmental abnormalities (such as enamel hypoplasia, dentinogenesis imperfecta etc.)

  • children with mental disabilities or systemic diseases.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Division of Pedodontics, Faculty of Dental Medicine Bucharest Romania

Sponsors and Collaborators

  • Carol Davila University of Medicine and Pharmacy

Investigators

  • Principal Investigator: Andreea C Didilescu, DDS, PhD, Carol Davila University of Medicine and Pharmacy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andreea Didilescu, DDS, Vice dean for Research, Professor, Carol Davila University of Medicine and Pharmacy
ClinicalTrials.gov Identifier:
NCT03626740
Other Study ID Numbers:
  • PN-III-P4-ID-PCE-2016-0506
First Posted:
Aug 13, 2018
Last Update Posted:
Aug 6, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andreea Didilescu, DDS, Vice dean for Research, Professor, Carol Davila University of Medicine and Pharmacy
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 6, 2021